Medication: Clinical trial

Journal articles and book chapters

06-21-2018 | Canagliflozin | Article

Canagliflozin and renal outcomes in type 2 diabetes: Results from the CANVAS program randomized clinical trials

Perkovic V et al. Lancet Diabetes Endocrinol 2018. doi: 10.1016/S2213-8587(18)30141-4

06-20-2018 | Ipragliflozin | Article

Ipragliflozin add-on therapy to a GLP-1 receptor agonist in Japanese patients with type 2 diabetes (AGATE): A 52-week open-label study

Ishihara H et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0455-8

06-14-2018 | Hypoglycemia | Article

Hypoglycemia, cardiovascular outcomes, and death: The LEADER experience

Zinman B et al. Diabetes Care 2018: dc172677. doi: 10.2337/dc17-2677

06-14-2018 | Dulaglutide | Article

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): A multicenter, open-label, randomized trial

Tuttle KR et al. Lancet Diabetes Endocrinol 2018. doi: 10.1016/S2213-8587(18)30104-9

06-13-2018 | Oral combination medications | Article

A randomized controlled trial of dapagliflozin plus once-weekly exenatide versus placebo in individuals with obesity and without diabetes: Metabolic effects and markers associated with bodyweight loss

Pereira MJ et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0449-6

06-12-2018 | Empagliflozin | Article

Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: A randomized controlled trial (E-LIFT trial)

Kuchay MS et al. Diabetes Care 2018: dc180165. doi: 10.2337/dc18-0165

06-12-2018 | Blood glucose monitoring | Article

Long-term effect of the color record method in self-monitoring of blood glucose on metabolic parameters in type 2 diabetes: A 2-year follow-up of the Color IMPACT study

Nishimura A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0457-6

06-12-2018 | Insulin | Article

A randomized controlled trial comparing efficacy and safety of insulin glargine 300 units/mL versus 100 units/mL in older people with type 2 diabetes: Results from the SENIOR study

Ritzel R et al. Diabetes Care 2018: dc180168. doi: 10.2337/dc18-0168

06-11-2018 | Diabetic foot | Article

Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial

Park KH et al. Diabetes Res Clin Prac 20184 142: 335–344. doi: 10.1016/j.diabres.2018.06.002

06-06-2018 | Gestational diabetes | Article

Using technology to support care in gestational diabetes mellitus: Quantitative outcomes of an exploratory randomised control trial of adjunct telemedicine for gestational diabetes mellitus (TeleGDM)

Rasekaba TM et al. Diabetes Res Clin Prac 2018; 142: 276–285. doi: 10.1016/j.diabres.2018.05.049

06-06-2018 | Lifestyle interventions | Article

A peer-support lifestyle intervention for preventing type 2 diabetes in India: A cluster-randomized controlled trial of the Kerala Diabetes Prevention Program

Thankappan KR et al. PLoS Med 2018; 15: e1002575. doi: 10.1371/journal.pmed.1002575

05-31-2018 | Insulin glargine | Article

Similar intrapatient blood glucose variability with LY2963016 and Lantus® insulin glargine in patients with type 1 (T1D) or type 2 diabetes, including a Japanese T1D subpopulation

Nishiyama H et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0450-0

05-30-2018 | Cardiovascular outcomes | Article

Serial measurement of natriuretic peptides and cardiovascular outcomes in patients with type 2 diabetes mellitus in the EXAMINE trial

Jarolim P et al. Diabetes Care 2018. doi: 10.2337/dc18-0109

05-25-2018 | Oral combination medications | Article

Characterization of the open-label lead-in period of two randomized controlled phase 3 trials evaluating dapagliflozin, saxagliptin, and metformin in type 2 diabetes

Mathieu C et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0445-x

05-15-2018 | Type 1 diabetes | Article

Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycemia or poorly controlled glycemia after kidney transplantation (TRIMECO): A multicenter, randomized controlled trial

Lablanche S et al. Lancet Diabetes Endocrinol 2018. doi: 10.1016/S2213-8587(18)30078-0

05-14-2018 | Insulin glargine | Article

Characteristics of insulin-naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: A meta-analysis of individual participant data from 3 randomized clinical trials

Cummings MH et al. Clin Diabetes Endocrinol 2018; 4: 10. doi: 10.1186/s40842-018-0059-2

05-11-2018 | Artificial pancreas systems | Article

Randomized outpatient trial of single- and dual-hormone closed-loop systems that adapt to exercise using wearable sensors

Castle JR et al. Diabetes Care 2018. doi: 10.2337/dc18-0228

05-08-2018 | Type 2 diabetes | Review | Article

Type 2 diabetes in youth: New lessons from the SEARCH study

Jensen ET, Dabelea D. Curr Diab Rep 2018; 18: 36. doi: 10.1007/s11892-018-0997-1

05-08-2018 | Cardiovascular disorders | Article

Sex-specific relevance of diabetes to occlusive vascular and other mortality: A collaborative meta-analysis of individual data from 980,793 adults from 68 prospective studies

Prospective Studies Collaboration and Asia Pacific Cohort Studies Collaboration. Lancet Diabetes Endocrinol 2018; Advance online publication. doi: 10.1016/S2213-8587(18)30079-2

05-04-2018 | Gestational diabetes | Article

The post-HAPO situation with gestational diabetes: The bright and dark sides

Lapolla A, Metzger BE. Acta Diabetol 2018; Advance online publication. doi: 10.1007/s00592-018-1146-7

Next Previous